Search - tctmd.com

Displaying 1 - 20 of 123

Sort: Relevancy | Date

News Conference News AHA 2025

Stopping DOACs After Successful AF Ablation Feasible in Low-risk Patients: OCEAN

Michael O'Riordan

November 08, 2025

News Conference News ESC 2025

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

Michael O'Riordan

August 29, 2025

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

News Conference News European Congress on Obesity 2025

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Michael O'Riordan

May 13, 2025

News Daily News

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Michael O'Riordan

April 22, 2025

News Opinion CV Team Dispatch

March 2025 Dispatch for the CV Team

L.A. McKeown

March 21, 2025

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

L.A. McKeown

March 06, 2025

News Daily News

No Spike in Cardiac Arrests, Deaths in Young Athletes During COVID-19

Todd Neale

February 26, 2025

News Daily News

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Yael L. Maxwell

February 20, 2025

News Daily News

Aspirin Use for Primary Prevention Declining in US: NHANES

Michael O'Riordan

January 24, 2025

News Features

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Michael O'Riordan

January 17, 2025

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Daily News

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

Michael O'Riordan

November 13, 2024

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Daily News

Good News for CV Recovery After COVID-19 Vaccine Myocarditis

Yael L. Maxwell

August 29, 2024

News Daily News

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Yael L. Maxwell

August 16, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Yael L. Maxwell

July 10, 2024

News Conference News ESC Heart Failure 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

Advertisement

Stopping DOACs After Successful AF Ablation Feasible in Low-risk Patients: OCEAN

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

March 2025 Dispatch for the CV Team

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

No Spike in Cardiac Arrests, Deaths in Young Athletes During COVID-19

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Aspirin Use for Primary Prevention Declining in US: NHANES

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Good News for CV Recovery After COVID-19 Vaccine Myocarditis

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content